Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
12/2003
12/04/2003WO2003016561A3 Method for the production of cna
12/04/2003WO2003005969A3 Tetrahydropurinones as corticotropin releasing factor
12/04/2003WO2002073208A3 Anti-epileptogenic agents
12/04/2003US20030225278 Process for preparing 2, 6-diaminopurine derivatives
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225252 PNA monomer and precursor
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225038 Adenosine receptor antagonists and methods of making and using the same
12/03/2003EP1366056A4 Preparation of deoxynucleosides
12/03/2003EP1366056A2 Preparation of deoxynucleosides
12/03/2003EP1366048A2 Pyrazolopyridine derivatives
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003CN1460106A Process for producing 2,6-dihalogenopurine
12/03/2003CN1460105A 黄嘌呤磷酸二酯酶v抑制剂 Xanthine phosphodiesterase inhibitor v
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
11/2003
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003074508B1 Compounds and methods of treating cell proliferative diseases
11/27/2003WO2003063876A3 Methods of treating patients suffering from movement disorders
11/27/2003WO2003022209A3 Crystalline forms of valacyclovir hydrochloride
11/27/2003US20030220352 Benzylated PDE4 inhibitors
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/26/2003EP1363644A2 Modulation of gsk-3beta activity and its different uses
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/20/2003WO2003041647A3 Synthesis and purification of valacyclovir
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003US20030216412 Methanocarba cycloakyl nucleoside analogues
11/19/2003EP1178046B1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
11/19/2003EP0874631B1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
11/19/2003CN1128149C 6,9-disubsituted 2-[trans-(4-aminocyclohexyl)amino]purines
11/18/2003US6649797 Contacting protein with a compound that is capable of stable reversible binding with basic amino acid residues of nuclear localization signal of protein for inactivating a nuclear localization signal of a protein
11/18/2003US6649759 Pyrazolo(1,5-a)pyrimidine derivatives; treating feeding, cardiovascular and psychological disorders
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/13/2003WO2003093461A2 Genomic library of cyanophage s-2l and functional analysis
11/13/2003WO2003048190A3 Acyclovir-peptide analogs
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022219A3 Biarylamino purine antiproliferative agents
11/13/2003US20030212082 Controlling neovascularization; angiogenesis inhibitors; therapy for strokes, cardiovascular disorders; antitumor agents; antidiabetic agents; antiarthritic agents; psoriasis
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003CA2483706A1 Genomic library of cyanophage s-2l and functional analysis
11/12/2003EP1361223A1 Method of manufacture of 1,3-oxathiolane nucleosides
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1140937B1 Antiviral nucleoside analogues
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/11/2003US6646125 Intermediates for viricides used to treat HIV
11/06/2003WO2003091231A1 Pna monomer and precursor
11/06/2003WO2003026589A3 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
11/06/2003WO2003018745A3 Method of screening for drug hypersensitivity reaction
11/06/2003US20030207883 Indazole benzimidazole compounds
11/06/2003US20030207879 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy
11/06/2003US20030207431 Properties of mycophenolic acid inhibition of IMPDH (inosine-5'-monophosphate dehydrogenase) that allow the development of the immunoassay; drug conjugates with an uncompetitive inhibitor of IMPDH, mycophenolic acid
11/05/2003EP1268480B1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
11/04/2003US6642424 Diels-Alder process; antitumor agents
11/04/2003US6642231 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
11/04/2003US6642230 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
10/2003
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003US20030204080 Such as 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl) adenine; for treatment of HIV
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/29/2003EP1357185A1 4-[(3-methyl-2(3H)-benzothiazolyliden)methylene]-quinoline and -pyridine derivatives as reporter groups in probes for analysis of nucleic acids
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003CN1125823C Ganciclovir sodium hydrate and its preparing process and application
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003US20030199693 Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives displaying inhibitory activies on PDE-5 phosphodiesterase
10/23/2003US20030199528 Such as cis-8-(2-aminocyclohexylamino)-7-benzyl-3-methyl-1-(2-oxo-2-phenylehtyl)-3,7-dihydropurine-2,6-dione for inhibition of dipeptidyl peptidase-IV (DPP-IV); for treatment of diabetes/obesity
10/22/2003EP1353922A1 Cyclin dependent kinase inhibiting purine derivatives
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1056744B1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
10/22/2003CN1125068C Process for prodn. of purine derivatives
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003CA2154999C Deoxygenation of cis vicinal diols
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003084958A1 Production method of 2,6-dihalopurine
10/16/2003WO2003084957A1 Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof
10/16/2003US20030195332 PNA monomer and precursor
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030194375 Anti-epileptogenic agents
10/15/2003EP1352910A1 New analogs of nitrobenzylthioinosine
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003CN1449387A Improved methods of synthesis for 9-substituted hypoxanthine derivatives
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/14/2003CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
10/09/2003US20030191312 Preparing a C2-substituted purine compound, by reacting a C2-halogenated purine with a boronic acid, a hydroxy or amine compounds; dehydrohalogenation, amination, carboxylation; chemical intermediates
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191122 Antidepressants; Alzheimer's disease; Parkinson's disease; central nervous system disorders
10/09/2003US20030191086 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
10/08/2003EP1349857A1 Purine derivatives as purinergic receptor antagonists
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 120